Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from Fox Chase Cancer Center: MDR-reversing agents

June 2, 1999

Bavarian Nordic's tyrosinase vector enters safety study in Germany

June 2, 1999

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

June 1, 1999

Novel matrix metalloproteinase inhibitor selectively inhibits rat osteosarcoma lung metastasis

June 1, 1999

Imidazole-based protein farnesyltransferase inhibitors for cancer

June 1, 1999

More on protein farnesyltransferase inhibitors in development at Merck

June 1, 1999

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

June 1, 1999

Recombinant enzyme plus gene therapy: a unique combination therapy for cancer

May 31, 1999

CPMP recommends expanded approval of Temodal for brain tumor therapy

May 31, 1999

Ilex initiates clinical testing of vitamin D3 analogue

May 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...